GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Adynxx ADYX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Adynxx — daily ADYX Delayed
Market value
$82
Last close × shares
Volume
16.3k
Shares, 30 Oct 2026

About Adynxx

Its shares trade under the ticker ADYX. It has been listed since 12 October 1998. In the fiscal year to 31 December 2018, it reported revenue of $2.2m and a net loss of $8.4m. At that date it held total assets of $9.7m and shareholders' equity of $8.3m.

Adynxx, Inc. is a clinical stage biopharmaceutical company. The company is headquartered in San Francisco, California. The firm is focused on development of non-opioid therapeutics for the treatment of pain and inflammatory diseases. Its AYX platform utilizes a proprietary technology of non-opioid, disease-modifying transcription factor decoys. Its pipeline includes brivoligide and AYX2. Brivoligide product candidate is a potent and selective inhibitor of the transcription factor EGR1. Brivoligide is being developed for the prevention of post-surgical pain. AYX2 is a potent inhibitor of Kruppel-like Factors (KLF) six, nine and 15, transcription factors that maintain neuronal and glial activities involved in pain. AYX2 is being developed for the long-term suppression of chronic pain.

Figures and description from our data supplier, not checked against the company's own report.

More about Adynxx →

How it makes its money

Revenue, year to 31 Dec 2016

  • Two Thousand Fifteen MIST Therapy [Member] $10.2m · 55.9%
  • Two Thousand Fourteen MIST Therapy [Member] $8.7m · 47.7%

Latest on Adynxx

Our reporting

We have not reported on Adynxx yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Adynxx's ticker?

Adynxx trades as ADYX on its US listing, under ISIN US00784D1037.

What was Adynxx's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.